Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and ...

McKesson Corp. has announced plans to separate its Medical-Surgical Solutions segment into an independent company. This strategic move is aimed at sharpening McKesson’s focus on higher-growth, higher- ...

Cold chain monitoring solutions have become indispensable to the biopharma business for managing complicated supply chains.

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...

Quantum Biopharma Ltd. QNTM shares climbed on Friday after the company disclosed a wide-reaching settlement agreement with ...

Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...

Healthcare & Pharmaceuticalscategory· May 8, 2025 India's Biocon posts higher quarterly profit on boost from generics, biosimilar business Indian biopharma firm Biocon's profit more than doubled ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost its position in ...